Home/Filings/4/0001582945-19-000024
4//SEC Filing

Lanphere Michael A. 4

Accession 0001582945-19-000024

CIK 0001425627other

Filed

Sep 16, 8:00 PM ET

Accepted

Sep 17, 3:35 PM ET

Size

7.0 KB

Accession

0001582945-19-000024

Insider Transaction Report

Form 4
Period: 2019-08-28
Lanphere Michael A.
V.P. of Legal Affairs10% Owner
Transactions
  • Purchase

    Common Stock

    2019-08-28$0.10/sh+5,206,430$520,64350,144,878 total
  • Purchase

    Common Stock

    2019-08-28$0.00/sh+21,400,745$96,30371,545,623 total
Footnotes (2)
  • [F1]The Reporting Person acquired 5,206,430 shares of the Issuer's common stock in exchange for 520,643 shares of the Issuer's Series A Preferred Stock pursuant to the terms of a Share Exchange Agreement. The exchange was agreed to in order to assist the Issuer in complying with the closing conditions of an Asset Purchase Agreement with IDTEC, LLC.
  • [F2]The Reporting Person acquired 21,400,745 shares of the Issuer's common stock in exchange for a $96,303.35 reduction in the amount the Issuer owes the Reporting Person under certain promissory notes. The transaction was documented with a Stock Purchase Agreement and was completed in order to assist the Issuer in complying with the closing conditions of an Asset Purchase Agreement with IDTEC, LLC.

Issuer

TransBiotec, Inc.

CIK 0001425627

Entity typeother

Related Parties

1
  • filerCIK 0001630553

Filing Metadata

Form type
4
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 3:35 PM ET
Size
7.0 KB